Objectives To update and revalidate the Cyber Paranoia and Fear Scale to reflect current technological contexts and examine its relevance to digital health readiness and engagement. Methods Using an online community sample (n=433), exploratory factor analysis was conducted to examine the factor structure of the revised item pool. Items were refined through consultation with Patient and Public Involvement and Engagement groups to ensure contemporary relevance and clarity. Results Analysis supported a four-factor structure representing artificial intelligence (AI) and digital dependence…
[Sponsored] In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable. The post Closing the Quality-Affordability Gap in Workplace Mental Health appeared first on MedCity News .
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio for a pipeline based on a novel payload.
This cohort study examines the association of primary care–initiated continuous glucose monitoring with hemoglobin A1c levels and use of acute health care services among patients with insulin-treated diabetes.
As clinicians, we learn not to be agreeable, we learn to challenge and sit in discomfort. We ask the hard questions underneath the one being asked. That is the work these tools are not yet built to do. The post AI in Mental Health: Why Clinicians Need to Be in the Room appeared first on MedCity News .
The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage. The post When Evidence Gap Becomes a Commercial Liability appeared first on MedCity News .
A month after Genentech confirmed the restructuring of its early development group, the Roche subsidiary has now disclosed that this has formed part of a round of 103 layoffs.
Exact Imaging is looking to broaden uptake of its high-resolution micro-ultrasound system for prostate cancer screening and is boosting its commercial team to help.
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney disease drug candidates.
Aurenar’s V-Link, a non-invasive nerve stimulation device for preventing brain hemorrhage complications, just won FDA breakthrough device designation after early trials showed it cut cerebral vasospasm by more than 40%. The post This Ear-Based Device Could Save Patients from Brain Bleed Complications appeared first on MedCity News .
Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists. The post Color Broadens Cancer Expert Medical Opinion Program appeared first on MedCity News .
Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in the 340B drug discount program. The post Debunked Episode 28: A Little More Transparency, A Little More Action appeared first on MedCity News .
The question facing hospital cybersecurity leaders today is no longer whether they will be collateral damage in a broader war; it’s how to reckon with adversaries who will target healthcare for ideological or political reasons — hackers may not have any particular interest in quick resolutions. The post Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It appeared first on MedCity News .
Without knowledge of the exact amount providers billed and middlemen charged in fees, OPM can’t fix payment discrepancies. The post Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data appeared first on MedCity News .
Are we genuinely building long-term preparedness infrastructure, or are we repeatedly improvising our way from one outbreak cycle to the next? The post Hantavirus Is the Warning Signal America Should Not Ignore appeared first on MedCity News .
Patients are trying to navigate insurance confusion, coordinate care, manage prescriptions, and understand the following steps that often feel unclear. Static chatbots were never built for this level of responsibility. Agentic AI is. Or at least that is the idea. The post What Happens When AI Stops Answering and Starts Handling Healthcare Tasks? appeared first on MedCity News .
The U.S., Mexico and Canada will continue negotiating about potential adjustments to the trilateral free trade agreement, which will remain in place until at least 2036.
A Fosun Pharma subsidiary has paid Junshi Biosciences 215 million yuan ($32 million) for Chinese rights to a near-approval autoimmune disease drug candidate.
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care. The post Evernorth Invests $100M for AI Specialty Pharmacy Program appeared first on MedCity News .
In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women’s health research. The post MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative appeared first on MedCity News .